Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Finance lease, right-of-use asset, after accumulated amortization Finance Lease, Right-of-Use Asset, after Accumulated Amortization Innovatus Life Sciences Lending Fund Innovatus Life Sciences Lending Fund [Member] Innovatus Life Sciences Lending Fund Shares outstanding (in shares) Preferred Stock, Shares Outstanding 2024 Long-Term Debt, Maturity, Year Two Number of monthly installments Debt Instrument, Number Of Monthly Installments Debt Instrument, Number Of Monthly Installments Debt Instrument [Axis] Debt Instrument [Axis] Total lease liabilities Finance Lease, Liability Monthly payment Purchase Obligation, Monthly Payments Purchase Obligation, Monthly Payments Additional paid-in capital Additional Paid in Capital Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Issuance of stock from vested restricted stock units and payment of employees' taxes Stock Issued During Period, Value, Restricted Stock Award, Forfeitures Termination of agreement Contract With Customer, Termination, Consideration Receivable Contract With Customer, Termination, Consideration Receivable Financial Instruments [Domain] Financial Instruments [Domain] 2026 Finance Lease, Liability, to be Paid, Year Four Statistical Measurement [Domain] Statistical Measurement [Domain] Blue Shield Blue Shield [Member] Blue Shield Schedule of Future Minimum Rental Payments for Operating Leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Exercise of stock options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of stock from vested restricted stock units and payment of employees' taxes (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Operating leases Operating Lease, Weighted Average Discount Rate, Percent Term loan, interest rate Debt Instrument, Interest Rate, Stated Percentage Share-Based Payment Arrangement [Abstract] Royalty obligation, percent of net sales Royalty Obligation, Percentage of Sales Royalty Obligation, Percentage of Sales Thereafter Finance Lease, Liability, to be Paid, Due after Year Four Finance Lease, Liability, to be Paid, Due after Year Four Property and equipment, net Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Stock-Based Compensation Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block] 2025 Finance Lease, Liability, to be Paid, Year Three Net loss Net loss Net Income (Loss) Attributable to Parent Schedule of Fair Value Assumptions, Employee Stock Purchase Plan Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Deferred rent credit Deferred Rent Credit Leases Lessee, Finance Leases [Text Block] Anti-dilutive securities excluded from computation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2022 (remaining) Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Schedule of Future Minimum Aggregate Payments for Outstanding Borrowings Schedule of Maturities of Long-Term Debt [Table Text Block] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid [Abstract] Equity Component [Domain] Equity Component [Domain] Janssen Promotion Agreement Janssen Promotion Agreement [Member] Janssen Promotion Agreement Leases Lessee, Operating Leases [Text Block] Amortization of lease assets Finance Lease, Right-of-Use Asset, Amortization Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Plan Name [Axis] Plan Name [Axis] Supplemental disclosure of non-cash items: Supplemental Cash Flow Elements [Abstract] Accrued purchases of goods and services Accrued Purchase, Goods and Services, Current Accrued Purchase, Goods and Services, Current Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Forfeited, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of operating segments Number of Operating Segments Lease Contractual Term [Domain] Lease Contractual Term [Domain] Unrecognized compensation cost related to stock purchase Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Plan Name [Domain] Plan Name [Domain] 2022 (remaining) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] 2023 Operating Leases, Future Minimum Payments, Due in Two Years Employee stock purchase plan Employee Stock [Member] Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Term loan, paid in-kind loans issued Debt Instrument, Paid In Kind Loans Issued Debt Instrument, Paid In Kind Loans Issued Award Type [Axis] Award Type [Axis] Warrant expiration September 7, 2024 Expiration Sep 7, 2024 [Member] Expiration Sep 7, 2024 New Accounting Pronouncement, Early Adoption [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Operating lease liabilities Less: current portion Operating Lease, Liability, Current Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Operating expenses: Costs and Expenses [Abstract] Office Office [Member] Office Lender Name [Axis] Lender Name [Axis] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Warrant expiration March 31, 2026 Expiration Mar 31, 2026 [Member] Expiration Mar 31, 2026 Initial license fee License Agreement, Initial License Fee License Agreement, Initial License Fee Borrowings-non-current portion, net of discounts and debt issuance costs Long-Term Debt, Excluding Current Maturities Total liabilities Liabilities Operating leases Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Issuance of stock in public offering, net of issuance costs of $4,435 Stock Issued During Period, Value, New Issues Accrued and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Property and Equipment Property, Plant and Equipment [Table Text Block] Shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Medicare Medicare [Member] Medicare Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Assets: Assets, Fair Value Disclosure [Abstract] Outstanding, December 31, 2021 (in dollars per share) Outstanding, March 31, 2022 (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Borrowings Debt Disclosure [Text Block] Finance Lease, Liability, Payment, Due [Abstract] Finance Lease, Liability, to be Paid [Abstract] Product and Service [Domain] Product and Service [Domain] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Entity Shell Company Entity Shell Company Warrant expiration December 7, 2025 Expiration Dec 7, 2025 [Member] Expiration Dec 7, 2025 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Weighted-average remaining lease term (years) Weighted-Average Remaining Lease Term [Abstract] Weighted-Average Remaining Lease Term Financial Instrument [Axis] Financial Instrument [Axis] 2025 Long-Term Debt, Maturity, Year Three Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Current Other Assets Increase (Decrease) in Prepaid Expense and Current Other Assets Accounts Receivable, Net Receivable Benchmark [Member] Receivable Benchmark Revenue Benchmark Revenue Benchmark [Member] Document Period End Date Document Period End Date Accrued payroll and related expenses Accrued Salaries, Current United Healthcare United Healthcare [Member] United Healthcare Total assets Assets Debt Disclosure [Abstract] Supplier [Domain] Supplier [Domain] Income Statement Location [Axis] Income Statement Location [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accrued and other current liabilities Accrued and other current liabilities Accrued Liabilities, Current Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Variable lease cost Variable Lease, Cost Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Amortization of debt discount and debt issuance costs Amortization of Debt Issuance Costs and Discounts Customer [Axis] Customer [Axis] Schedule of Fair Value Assumptions, Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Lease obligations, net of current portion Finance Lease, Liability, Noncurrent Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Award Type [Domain] Award Type [Domain] Stock options, cost not yet recognized, remaining weighted average vesting period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Proceeds from common stock issued under Employee Stock Purchase Plan Proceeds from Stock Plans Prometheus Laboratories Prometheus Laboratories, Inc. [Member] Prometheus Laboratories, Inc. Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Entity Registrant Name Entity Registrant Name Issuance of stock in public offering, net of issuance costs of $4,435 (in shares) Stock Issued During Period, Shares, New Issues Supplier Concentration Risk Supplier Concentration Risk [Member] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate 2019 Incentive Award Plan Incentive Award Plan, 2019 [Member] Incentive Award Plan, 2019 Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Entity Address, City or Town Entity Address, City or Town Leases [Abstract] Leases [Abstract] Interest Long-term Debt, Undiscounted Interest Amount Long-term Debt, Undiscounted Interest Amount Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] Number of annual vesting installments Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Period, Number Of Annual Installments Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Period, Number Of Annual Installments Fair Value Measurements Fair Value Disclosures [Text Block] Cash paid for amounts included in the measurement of lease liabilities Cash Flow Information, Operating and Finance Lease Payments [Abstract] Cash Flow Information, Operating and Finance Lease Payments New Accounting Pronouncement, Early Adoption [Axis] Accounting Standards Update [Axis] Trading Symbol Trading Symbol Entity File Number Entity File Number Term loan, paid in-kind, interest rate Debt Instrument, Stated Interest Rate, Paid In-Kind Debt Instrument, Stated Interest Rate, Paid In-Kind Accrued interest Interest Payable, Current Research and development expenses Research and Development Expense Sale of stock, percentage of ownership after transaction Sale of Stock, Percentage of Ownership after Transaction Options exercisable, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Awards granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted stock units Restricted Stock Units (RSUs) [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Vested and expected to vest, March 31, 2022 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Money market funds, included in cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Common stock options Equity Option [Member] Accounts payable Increase (Decrease) in Accounts Payable Percent of total revenue Concentration Risk, Percentage Prepaid maintenance and insurance contracts Prepaid Maintenance and Insurance Contracts Prepaid Maintenance and Insurance Contracts Expected volatility rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Term loan, fee incurred upon payment of final installment Debt Instrument, Fee Amount Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Class of warrant or right, exercise price of warrants or rights (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Net loss per share, basic (in dollars per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three New Accounting Pronouncement, Early Adoption [Table] Accounting Standards Update and Change in Accounting Principle [Table] Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Collaboration agreement, collaboration expenses Collaboration Agreement, Collaboration Expenses Collaboration Agreement, Collaboration Expenses Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Equipment purchased under finance lease obligations Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Awards canceled, Weighted-Average Grant Date Fair Value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Healthcare insurers Healthcare Insurers [Member] Healthcare Insurers Lease Contractual Term [Axis] Lease Contractual Term [Axis] Entity Interactive Data Current Entity Interactive Data Current Sale of stock, number shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Office and Laboratory Office and Laboratory [Member] Office and Laboratory Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Aetna Aetna [Member] Aetna Money market funds, included in cash and cash equivalents Money Market Funds [Member] Accumulated Deficit Retained Earnings [Member] Total lease cost Lease, Cost Common Stock Common Stock [Member] Maximum employee payroll deduction percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Schedule of Non-cash Stock-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Summary of Lease Costs Lease, Cost [Table Text Block] Shares that remain available for future awards (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Revenue Recognition Revenue [Policy Text Block] Statement [Table] Statement [Table] Awards released, Weighted-Average Grant Date Fair Value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Term loan, effective interest rate Debt Instrument, Interest Rate, Effective Percentage Operating lease, renewal term Lessee, Operating Lease, Renewal Term Document Quarterly Report Document Quarterly Report Furniture and fixtures Furniture and Fixtures [Member] Current assets: Assets, Current [Abstract] Net exercise of common stock warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised, Net Stock Issued During Period, Shares, Warrants Exercised, Net Non-current operating lease liabilities Lease obligations, net of current portion Operating Lease, Liability, Noncurrent Operating lease annual increase in base rent payment percent Operating Lease, Annual Increase In Base Rent Payment, Percent Operating Lease, Annual Increase In Base Rent Payment, Percent Statistical Measurement [Axis] Statistical Measurement [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Leasehold improvements Leasehold Improvements [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Recurring Fair Value, Recurring [Member] 2026 Operating Leases, Future Minimum Payments, Due in Five Years Computer equipment and software Computer Equipment and Software [Member] Computer Equipment and Software Segment Reporting Segment Reporting, Policy [Policy Text Block] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Expired, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Document Fiscal Year Focus Document Fiscal Year Focus Total minimum lease payments Operating Leases, Future Minimum Payments Due Statement [Line Items] Statement [Line Items] Principal payments on finance lease obligations Financing cash out flows from finance leases Finance Lease, Principal Payments Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Outstanding, December 31, 2021 (in shares) Outstanding, March 31, 2022 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] 2022 Operating Leases, Future Minimum Payments Due, Next 12 Months Selling, general and administrative expenses Selling, General and Administrative Expense Loss Contingencies [Table] Loss Contingencies [Table] Accrued royalties Accrued Royalties, Current Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Vested and expected to vest, March 31, 2022 (in shares), Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Operating lease cost Operating Lease, Expense Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Document Transition Report Document Transition Report Local Phone Number Local Phone Number Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Allegheny Health Network Research Institute Allegheny Health Network Research Institute [Member] Allegheny Health Network Research Institute Loss from operations Operating Income (Loss) Shipping and Handling Shipping and Handling [Member] Recent Accounting Pronouncements Not Yet Adopted, Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Weighted-average discount rate Weighted-Average Discount Rate [Abstract] Weighted-Average Discount Rate Shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Goodwill Goodwill Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Depreciation and amortization Cost, Depreciation and Amortization 2017 Term loan Term 2017 [Member] Term 2017 Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Deferred tax liabilities Deferred Income Tax Liabilities, Net Par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional Paid-In Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Costs of revenue Cost of Goods and Services Sold Weighted-average number of shares used to compute net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Expected volatility rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Loss Contingencies [Line Items] Loss Contingencies [Line Items] Term loan, covenant, number of days to cure covenant if performance measure is not met Debt Instrument, Covenant, Number Of Days To Cure If Performance Measure Is Not Met Debt Instrument, Covenant, Number Of Days To Cure If Performance Measure Is Not Met Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Common stock, $0.001 par value; 200,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 16,258,807 and 16,164,994 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Awards granted, Weighted-Average Grant Date Fair Value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Fair Value, Financial Instrument Measured on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Shares authorized (in shares) Preferred Stock, Shares Authorized Product Concentration Risk Product Concentration Risk [Member] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Total Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Loan payable Loans Payable [Member] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Issuance of common stock warrant in exchange for retirement of common stock Adjustments to Additional Paid in Capital, Warrant Issued Current liabilities: Liabilities, Current [Abstract] Term loan borrowings Proceeds from Issuance of Long-Term Debt Proceeds from exercise of stock options Proceeds from Stock Options Exercised Shares issued (in shares) Common Stock, Shares, Issued Vested and expected to vest, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] Purchase obligation, due in year one Purchase Obligation, to be Paid, Year One Interest on finance lease liabilities Finance Lease, Interest Expense Costs incurred, but not paid, in connection with capital expenditures Capital Expenditures Incurred but Not yet Paid Income Statement Location [Domain] Income Statement Location [Domain] Licensing Agreements License Agreement Terms [Member] Finance lease liabilities - current Less: current portion Finance Lease, Liability, Current AHN Collaboration AHN Collaboration [Member] AHN Collaboration Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Issuance of stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Construction in progress Construction in Progress [Member] Entity Current Reporting Status Entity Current Reporting Status Other assets Other Assets, Noncurrent Prepaid product royalties Prepaid Royalties Stock Options, Additional Disclosures [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] 2023 Finance Lease, Liability, to be Paid, Year One Depreciation and amortization Depreciation, Depletion and Amortization Other Other Customer [Member] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Capital Royalty Partners II LP Capital Royalty Partners II LP [Member] Capital Royalty Partners II LP Term loan covenant, minimum unrestricted cash balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Issuance of stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Outstanding, December 31, 2021 (in shares) Outstanding, March 31, 2022 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Unamortized debt discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 2024 Finance Lease, Liability, to be Paid, Year Two Two Major Suppliers Two Major Suppliers [Member] Two Major Suppliers Operating cash out flows from operating leases Operating Lease, Payments Loan repayment Repayments of Long-Term Debt Government Government1 [Member] Government1 Stock options Share-Based Payment Arrangement, Option [Member] Other assets Increase (Decrease) in Other Noncurrent Assets Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Preferred stock Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Awards canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Total borrowings, net of discounts and debt issuance costs Long-Term Debt Other income (expense), net Other Nonoperating Income (Expense) Organization Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Shares issued in public offering, price per share (in dollars per share) Sale of Stock, Price Per Share Shares authorized (in shares) Common Stock, Shares Authorized Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Maximum Maximum [Member] Operating lease, rent expense Operating Leases, Rent Expense Retirement of common stock in exchange for common stock warrant Stock Repurchased and Retired During Period, Value Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other Financial Information Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities [Text Block] Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities Increase (decrease) in variable consideration Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Small Business Entity Small Business Schedule of Outstanding Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Restricted cash Restricted Cash Shipping and Handling Costs Cost of Goods and Service [Policy Text Block] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Stock options, unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount 2025 Operating Leases, Future Minimum Payments, Due in Four Years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Schedule of Concentration of Risk, by Risk Factor and Significant Payer Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Non-cash interest expense Paid-in-Kind Interest Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Medicare Advantage Medicare Advantage [Member] Medicare Advantage Retirement of common stock in exchange for common stock warrant (in shares) Stock Repurchased and Retired During Period, Shares Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Accounts receivable, net Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Term loan, covenant, revenue performance period Debt Instrument, Covenant, Revenue Performance Period Debt Instrument, Covenant, Revenue Performance Period Period for royalties to begin License Agreement, Period After Commercial Sales Begin For Royalties To Be Paid License Agreement, Period After Commercial Sales Begin For Royalties To Be Paid Total operating expenses Costs and Expenses Term loan, prepayment premium percentage Debt Instrument, Prepayment Premium Percentage Debt Instrument, Prepayment Premium Percentage Debt Instrument [Line Items] Debt Instrument [Line Items] Common stock Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Class of Stock [Line Items] Class of Stock [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Operating lease liabilities Total lease liabilities Operating Lease, Liability Future minimum royalty commitment Royalty Guarantees, Commitments, Amount Selling, general and administrative Selling, General and Administrative Expenses [Member] Total minimum lease payments Finance Lease, Liability, to be Paid Summary of Finance Lease, Liability, Maturity Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] Supplier [Axis] Supplier [Axis] Finance lease, term of contract Lessee, Finance Lease, Term of Contract Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Granted, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Advance royalties payment Advance Payment Advance Payment 2022 (remaining) Long-Term Debt, Maturity, Remainder of Fiscal Year Proceeds from public offering, net Sale of Stock, Consideration Received on Transaction Accounts payable Accounts Payable, Current Vested and expected to vest, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 2026 Long-Term Debt, Maturity, Year Four Less: accumulated depreciation and amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Non-cash lease expense Non-Cash Lease Expense Non-Cash Lease Expense Warrants to purchase common stock Warrant [Member] Entity Filer Category Entity Filer Category Janssen (SIMPONI) Janssen (SIMPONI) [Member] Janssen (SIMPONI) Proceeds from the issuance of common stock in public offering, gross Proceeds from Issuance of Common Stock Weighted-average number of shares used to compute net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Thereafter Lessee, Operating Lease, Liability, to be Paid, Due after Year Four Lessee, Operating Lease, Liability, to be Paid, Due after Year Four Options exercised, March 31, 2022 (in shares), Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price AVISE CTD Test AVISE CTD Test [Member] AVISE CTD Test Stock-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies (Note 6) Commitments and Contingencies Security Exchange Name Security Exchange Name Outstanding, December 31, 2021, Weighted Average Exercise Price (in dollars per share) Outstanding, March 31, 2022, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Laboratory equipment Laboratory Equipment [Member] Laboratory Equipment Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of June 30, 2022 and December 31, 2021 Preferred Stock, Value, Issued Warrant expiration January 19, 2026 Expiration Jan 19, 2026 [Member] Expiration Jan 19, 2026 Number of warrants exercised (in shares) Class of Warrant or Right, Number Of Warrants Exercised Class of Warrant or Right, Number Of Warrants Exercised Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Prepaid expenses and other current assets Prepaid Expense and Other Assets Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Leases Lessee, Leases [Policy Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Stock Option Plan Share-Based Payment Arrangement [Text Block] Finance leases Finance Lease, Weighted Average Discount Rate, Percent Term loan, annual reduction in prepayment penalty percentage Debt Instrument, Prepayment Premium Percentage, Annual Reduction Debt Instrument, Prepayment Premium Percentage, Annual Reduction Number of shares exchanged for warrants (in shares) Exchange Agreement, Number Of Shares Exchanged For Warrants Exchange Agreement, Number Of Shares Exchanged For Warrants Accrued clinical study activity Accrued Liabilities, Clinical Study, Current Accrued Liabilities, Clinical Study, Current Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Payments of taxes withheld on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and stockholders' equity Liabilities and Equity Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Term loan covenant, increase to interest rate Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] No expiration No expiration [Member] No expiration Level 2 Fair Value, Inputs, Level 2 [Member] Exchanging Stockholders Exchanging Stockholders [Member] Exchanging Stockholders Client Client [Member] Client Current Fiscal Year End Date Current Fiscal Year End Date Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Stock options, vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Payment of issuance costs related to public offering Payments of Stock Issuance Costs Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Annual increase in purchase commitments Purchase Obligation, Annual Increase In Commitment, Percentage Purchase Obligation, Annual Increase In Commitment, Percentage 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Diagnostic testing supplies Other Assets, Current Customer Concentration Risk Customer Concentration Risk [Member] Operating lease monthly base rent Operating Lease, Monthly Base Rent Operating Lease, Monthly Base Rent Queen Mary University Queen Mary University [Member] Queen Mary University Schedule of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Deferred offering costs reclassified to equity Deferred Offering Costs Reclassified to Equity Deferred Offering Costs Reclassified to Equity Total Long-term Debt, Including Undiscounted Interest Long-term Debt, Including Undiscounted Interest Entity Ex Transition Period Entity Ex Transition Period Stock options, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Options exercisable, March 31, 2022 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Collaboration fee Collaboration Agreement, Annual Collaboration Fee Collaboration Agreement, Annual Collaboration Fee Other Financial Information [Abstract] Other Financial Information Summary of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Cost of revenue Cost of Revenue Product and Service [Axis] Product and Service [Axis] Finance leases Finance Lease, Weighted Average Remaining Lease Term Fair Value Disclosures [Abstract] Interest expense Interest Expense Options exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Accrued and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Equity [Abstract] Awards released (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Tax Identification Number Entity Tax Identification Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Purchase obligation, to be paid remainder of fiscal year Purchase Obligation, to be Paid, Remainder of Fiscal Year Advertising expense Advertising Expense Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Total property and equipment Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Operating cash out flows from interest paid on finance leases Finance Lease, Interest Payment on Liability Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Paid in-kind note Payment in Kind (PIK) Note [Member] Warrant expiration April 1, 2026 Expiration Apr 1, 2026 [Member] Expiration Apr 1, 2026 Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Research and Development Research and Development Expense, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Concentration of Credit Risk and Other Risk and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Other accrued liabilities Other Accrued Liabilities, Current Accounting Standards Update [Domain] Accounting Standards Update [Domain] City Area Code City Area Code Stock issuance costs Estimated offering expenses for aggregate expenses Stock Issuance Costs Stock Issuance Costs Assets Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Purchase obligation Purchase Obligation Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other prepaid expenses and other current assets Other Prepaid Expense, Current Advertising and Marketing Costs Advertising Cost [Policy Text Block] Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] 2023 Long-Term Debt, Maturity, Year One Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Warrants issued to purchase redeemable convertible preferred stock (in shares) Class of Warrant or Right, Outstanding Less: imputed interest Finance Lease, Liability, Undiscounted Excess Amount Other non-current liabilities Other Liabilities, Noncurrent Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development Research and Development Expense [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Costs of revenue Cost of Sales [Member] Customer [Domain] Customer [Domain] 2024 Operating Leases, Future Minimum Payments, Due in Three Years